The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients

dc.contributor.authorAtamer, A.
dc.contributor.authorIlan, N.
dc.contributor.authorKocyigit, Y.
dc.contributor.authorToprak, G.
dc.contributor.authorOzbay, M.
dc.contributor.authorCelik, Y.
dc.date.accessioned2026-08-12T16:34:59Z
dc.date.issued2007
dc.departmentFırat Üniversitesi
dc.description76th Congress of the European-Atherosclerosis-Society -- JUN 10-13, 2007 -- Helsinki, FINLAND
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Atherosclerosis Soc
dc.identifier.doi10.1016/S1567-5688(07)71407-1
dc.identifier.endpage115
dc.identifier.issn1567-5688
dc.identifier.issue1
dc.identifier.pmid18230268
dc.identifier.scopus2-s2.0-39149096877
dc.identifier.scopusqualityN/A
dc.identifier.startpage115
dc.identifier.urihttps://doi.org/10.1016/S1567-5688(07)71407-1
dc.identifier.urihttps://hdl.handle.net/11508/44696
dc.identifier.volume8
dc.identifier.wosWOS:000247869100459
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofAtherosclerosis Supplements
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjecthypertension
dc.subjectleptin
dc.subjectADMA
dc.subjectinsulin resistance
dc.subjectMDA
dc.subjectlipoproteins
dc.titleThe role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients
dc.typeConference Object

Dosyalar